US 7592340
Quinoxalines useful as inhibitors of protein kinases
granted A61PA61P11/06A61P17/14
Quick answer
US patent 7592340 (Quinoxalines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P11/06, A61P17/14, A61P21/00, A61P25/00